Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL3290620

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
CC1=CC(=O)N(Nc2nc(-c3ccncc3)nc3scc(-c4cccs4)c23)C1=O
ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID CHEMBL3290620
Phase Preclinical
Structure Type MOL
InChI Key JCZKCLFATQQMAG-UHFFFAOYSA-N
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
2
Publications
0
Known Names

Molecular Properties

419.5
MW (Da)
4.12
ALogP
8
HBA
1
HBD
88.1
PSA (Ų)
0.50
QED
0
Ro5 Violations
4
Rot. Bonds

Drug Information

Molecule Type Small molecule
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C20H13N5O2S2
MW 419.49
Aromatic Rings 4
Heavy Atoms 29
NP-Likeness -1.56

Activity Summary

IC50 1 meas. best 5.68

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
RAW264.7
CHEMBL612557
 IC50 5.68 5.68 2110.0 1

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
RAW264.7 IC50 = 2110.0 nM 5.68 Antiinflammatory activity against mouse RAW264.7 cells assessed as reduction of ... 24813730

Literature References

PubMed DOI Target Context # Activities
24813730 10.1016/j.bmcl.2014.04.058 Inhibitor of nuclear factor kappa-B kinase subunit beta 2
24813730 10.1016/j.bmcl.2014.04.058 RAW264.7 2

Data from ChEMBL 36 via Core Engine